SkinBioTherapeutics appoints interim CEO as investigation continues
(Alliance News) - SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve out a way forward from the suspension and resignation of its past CEO. Read More